Year: 2022
Year: 2022
Information to be submitted for a GMO (GM Animals/GM Plants) Contained Use Notification under GMO (Contained Use) Regulations, 2001 to 2010.
Year: 2022
Information to be submitted for a Class 3/4 GMM contained use notification under the GMO (Contained Use) Regulations, 2001 to 2010
Year: 2022
Information to be submitted for a Class 1/2 GMM contained use notification under the GMO (Contained Use) Regulations, 2001 to 2010.
Year: 2022
Year: 2022
Year: 2022
Year: 2022
The GMO Register Entry provides significant details of the clinical trial. , December 2021
Year: 2021
This information note outlines the procedure involved in making a representation to the EPA in respect of this proposed deliberate release, GMO Register No: G0784-01; SNIF Notification No: B/IE/21/01. , December 2021
Year: 2021
Newspaper advertisement in accordance with Article 15 of the GMO (Deliberate Release) Regulations S.I. No 500 of 2003, informing members of the public of the proposed deliberate release and inviting representations. , December 2021
Year: 2021
Year: 2021
The GMO Register Entry provides significant details of the of the proposed treatment under the managed access programme.
Report of final results , April 2021
Year: 2021
Reporting of the final results of deliberate release into the environment of Genetically Modified Organisms used in investigational medicinal products
Year: 2021
This guidance document sets out the procedure for submitting confidential information to the EPA under Article 9 of the GMO (Contained Use) Regulations 2001 to 2010.
Year: 2021
Procedure for submitting confidential information under the Contained Use Legislation
Year: 2020
This flow chart shows the process and the timeframes involved when applying to the EPA for a consent for the contained use of a GMO/GMM
Year: 2020
Procedure for submitting Confidential Information for Deliberate Release applications
Year: 2020
An extract from the minutes of the EPA Board Meeting of 13 March 2020
Year: 2020
The GMO Register Entry provides significant details of the clinical trial.
Year: 2020
All documentation submitted in respect of this notification was taken into consideration by the EPA inspector in her report to the Board of the Agency.
